VISEN Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	632.65	203.59	347.78	626.46
Cash & Short-Term Investments	632.65	203.59	347.78	626.46
Cash Growth	210.75%	-41.46%	-44.48%	-
Accounts Receivable	0.17	-	-	-
Other Receivables	-	1.77	4.09	1.45
Receivables	0.17	1.77	4.09	1.45
Inventory	1.53	-	-	-
Prepaid Expenses	60.66	-	-	-
Other Current Assets	247.06	17.22	22.25	83.69
Total Current Assets	942.05	222.57	374.12	711.59
Property, Plant & Equipment	7.7	11.16	13.26	17.16
Other Intangible Assets	1.07	0.05	0.57	1.42
Other Long-Term Assets	26.48	60.04	55.85	11.1
Total Assets	977.3	293.82	443.8	741.27
Accounts Payable	2.83	11.12	1.01	27.98
Accrued Expenses	24.15	22.54	29.85	25.48
Short-Term Debt	170.12	-	-	-
Current Portion of Leases	2.58	2	2.55	4.67
Current Income Taxes Payable	1.94	2.67	1.85	2.57
Current Unearned Revenue	-	-	2.9	2.9
Other Current Liabilities	9.34	13.87	13.67	23.74
Total Current Liabilities	210.96	52.19	51.82	87.34
Long-Term Leases	4.29	0.36	1.1	1.33
Total Liabilities	215.24	52.55	52.92	88.67
Common Stock	0.08	0.07	0.07	0.07
Additional Paid-In Capital	-	1,523	1,523	1,523
Retained Earnings	-	-1,614	-1,431	-1,182
Treasury Stock	-0	-0.01	-0.01	-0.01
Comprehensive Income & Other	761.98	331.55	298.91	311.07
Shareholders' Equity	762.05	241.28	390.88	652.61
Total Liabilities & Equity	977.3	293.82	443.8	741.27
Total Debt	176.99	2.36	3.65	6
Net Cash (Debt)	455.66	201.23	344.13	620.46
Net Cash Growth	126.44%	-41.53%	-44.54%	-
Net Cash Per Share	4.40	2.15	3.68	-
Filing Date Shares Outstanding	109.04	9.34	9.34	-
Total Common Shares Outstanding	109.04	9.34	9.34	-
Working Capital	731.09	170.39	322.3	624.25
Book Value Per Share	6.99	25.83	41.85	-
Tangible Book Value	760.99	241.22	390.31	651.19
Tangible Book Value Per Share	6.98	25.83	41.79	-
Machinery	-	1.56	1.53	1.59
Leasehold Improvements	-	0.28	1.76	3.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.